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Background/introduction
ExAblate Neuro is the only technology that enables clin-
ical treatment of transcranial MR guided focused ultra-
sound. It is CE approved for the treatment of certain
neurological disorders and is under evaluation for addi-
tional regulatory approval.
We will review the existing applications and the lim-
itations of the current technology. Two of the key lim-
itations are the treatment envelope and the effects of
different skull on the effectiveness of the transcranial
ultrasound delivery.
Methods
Expanding the treatment envelope requires to overcome
technological barriers. The current clinical experience is
limited to anatomical targets that are limited to deep
and centralized locations in the brain. This is a signifi-
cant limitation since there are compelling clinical targets
that are located beyond the existing treatment envelope.
We will suggest treatment concepts which are being
developed to overcome these limitations and enable to
extend the treatment envelope.
Results and conclusions
The accumulated clinical experience with transcranial
focusing shows as significant variability of the acoustic
parameters which are applied during the treatments. It is
assumed that the skull is the most significant contributor
to this variability due to its non-homogenous and quite
variable characteristics. The variability has been studied
and found to be correlated with skull density parameters.
We will describe how patient selection criteria may be
applied to optimize the treatment for different patient
selection criteria.
Published: 30 June 2015
doi:10.1186/2050-5736-3-S1-O33
Cite this article as: Zadicario: ExAblate neuro transcranial treatment
considerations. Journal of Therapeutic Ultrasound 2015 3(Suppl 1):O33.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
InSightec, Tirat Carmel, Israel
Zadicario Journal of Therapeutic Ultrasound 2015, 3(Suppl 1):O33
http://www.jtultrasound.com/content/3/S1/O33
© 2015 Zadicario; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
